Skip to main content

Table 4 Prognostic factors associated with treatment failure (multivariate analysis)

From: Impact of rifampicin dose in bone and joint prosthetic device infections due to Staphylococcus spp: a retrospective single-center study in France

  OR [95% CI] p
Age 0,94 [0.91–0.97] 0.001
Sex 0.86 [0.30–2.44] 0.773
Rifampicin dosage, mg/kg/day 1,02 [0.9–1.15] 0.753
Treatment duration, days 1,05 [1.03–1.07] < 0.001
\